Results
4810
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
4,810 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BXPHARMA | ৳122.70 | -0.8% | -16.1% | ৳54.7b | ৳177.50 | PE10.3x | E15.6% | 2.9% | Pharmaceuticals & Biotech | ||
NATGATE | RM 2.15 | 12.6% | 48.3% | RM 4.4b | RM 1.98 | PE65.1x | E29.9% | 0.5% | Tech | ||
PEKAT | RM 0.98 | 3.2% | 108.5% | RM 622.4m | n/a | PE44.1x | E25.5% | 1.0% | Capital Goods | ||
INFOM | RM 1.54 | -3.8% | -13.0% | RM 925.9m | RM 1.69 | PE28.6x | E21.2% | n/a | Software | ||
P52 | S$0.54 | 0% | 38.5% | S$379.8m | n/a | PE10.6x | E12.8% | 4.3% | Capital Goods | ||
EMIL | ₹232.26 | 1.6% | 153.6% | ₹91.7b | ₹269.00 | PE48.6x | E18.3% | n/a | Retail | ||
SJS | ₹791.90 | -5.0% | 35.1% | ₹24.7b | ₹838.67 | PE29x | E21.7% | 0.3% | Automobiles | ||
524742 | ₹1,535.00 | 7.4% | 86.7% | ₹114.8b | ₹1,568.67 | PE25.5x | E11.7% | 0.3% | Pharmaceuticals & Biotech | ||
ASKAUTOLTD | ₹386.20 | -1.8% | n/a | ₹77.5b | ₹394.00 | PE43.8x | E29.3% | 0.3% | Automobiles | ||
HELI | ج.م9.56 | -1.7% | -6.6% | ج.م12.8b | ج.م20.77 | PE1.5x | E-57.6% | 14.0% | Real Estate Management and Development |